2019
DOI: 10.21518/2079-701x-2019-15-22-28
|View full text |Cite
|
Sign up to set email alerts
|

Successful management of severe bronchial asthma: the right choice of biologic therapy in properly selected patients

Abstract: Severe asthma along with the impact on the quality of life of those suffering from this disease leads to significant medical and social damage. Studies of the last decade indicate the leading role of eosinophilic inflammation of the bronchi as the basis of the pathogenesis of the T2 phenotype of bronchial asthma, which led to the development of targeted therapy. The most effective in this direction were preparations of humanized monoclonal antibodies directed against the main pro-inflammatory cytokines involve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 38 publications
(46 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?